Bisphenol A is an endocrine disrupting compound widely used in the production of polycarbonate plastics and epoxy resins. It is ubiquitously present in the environment, mostly in aquatic environments, with consequent risks to the health of aquatic organisms and humans. In the present study, we analysed the cytogenetic effects of bisphenol A on human lymphocytes using in vitro chromosomal aberrations and micronuclei assays. Lymphocyte cultures were exposed to five different concentrations of BP-A (0.20, 0.10, 0.05, 0.02 and 0.01 μg/mL) for 24 h (for chromosomal aberrations test) and 48 h (for micronuclei test). The concentration of 0.05 µg/mL represents the reference dose established by United States Environmental Protection Agency (US EPA); 0.02 μg/mL represents the higher concentration of unconjugated BP-A found in human serum and 0.01 μg/mL represents the tolerable daily intake established by European Union. Data obtained from both assays showed significant genotoxic effects of the bisphenol A at concentrations of 0.20, 0.10 and 0.05 μg/mL, whereas at the concentration of 0.02 μg/mL, we observed only a significant increase in the micronuclei frequency. Finally, at the concentration of 0.01 μg/mL, no cytogenetic effects were observed, indicating this latter as a more tolerable concentration for human health with respect to 0.05 μg/mL, the reference dose established by US EPA.

Clastogenic effects of bisphenol A on human cultured lymphocytes

SANTOVITO, Alfredo;CANNARSA, ELIO;SCHLEICHEROVA, DASA;CERVELLA, Piero
2018-01-01

Abstract

Bisphenol A is an endocrine disrupting compound widely used in the production of polycarbonate plastics and epoxy resins. It is ubiquitously present in the environment, mostly in aquatic environments, with consequent risks to the health of aquatic organisms and humans. In the present study, we analysed the cytogenetic effects of bisphenol A on human lymphocytes using in vitro chromosomal aberrations and micronuclei assays. Lymphocyte cultures were exposed to five different concentrations of BP-A (0.20, 0.10, 0.05, 0.02 and 0.01 μg/mL) for 24 h (for chromosomal aberrations test) and 48 h (for micronuclei test). The concentration of 0.05 µg/mL represents the reference dose established by United States Environmental Protection Agency (US EPA); 0.02 μg/mL represents the higher concentration of unconjugated BP-A found in human serum and 0.01 μg/mL represents the tolerable daily intake established by European Union. Data obtained from both assays showed significant genotoxic effects of the bisphenol A at concentrations of 0.20, 0.10 and 0.05 μg/mL, whereas at the concentration of 0.02 μg/mL, we observed only a significant increase in the micronuclei frequency. Finally, at the concentration of 0.01 μg/mL, no cytogenetic effects were observed, indicating this latter as a more tolerable concentration for human health with respect to 0.05 μg/mL, the reference dose established by US EPA.
2018
37
1
69
77
Santovito, A; Cannarsa ,E; Schleicherova, D; Cervella, P
File in questo prodotto:
File Dimensione Formato  
Santovito R1.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 504.25 kB
Formato Adobe PDF
504.25 kB Adobe PDF Visualizza/Apri
Santovito - BPA pre-print.docx

Accesso aperto

Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 180.53 kB
Formato Microsoft Word XML
180.53 kB Microsoft Word XML Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1624718
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 22
social impact